AIDS
184
10
12
134
Key Insights
Highlights
Success Rate
96% trial completion (above average)
Published Results
39 trials with published results (21%)
Research Maturity
134 completed trials (73% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
2.7%
5 terminated out of 184 trials
96.4%
+9.9% vs benchmark
21%
39 trials in Phase 3/4
29%
39 of 134 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 134 completed trials
Clinical Trials (184)
Protect and Improve Cluster of Differentiation 4 (CD4) Cells and B Cells Lymphocytes
Effectiveness of a Smoking Cessation Algorithm Integrated Into HIV Primary Care
Implementing Depression and Adherence Treatment
The Collaborative Care PrTNER Study
Efficacy and Safety of Immune Checkpoint Inhibitors for Refractory Opportunistic Infections in AIDS
Virologic and Immunologic Characteristics of Severe Mpox in Persons With Advanced HIV
Engaging Pharmacists to Advance Tobacco Treatment Service Delivery
HIV HOspital TEsting: Bringing the Hidden to Light in the Hospital Setting
A Randomized Clinical Trial to Evaluate Solutions for the Management of Virologic Failure on TLD in Sub-Saharan Africa
Screening for Hepatitis B, Hepatitis C and AIDS Viruses Using Dried Blood Spot
The DC Cohort Longitudinal HIV Status Neutral Study
Acute Effects of Cannabis on Cognition and Mobility in Older HIV-infected and HIV-Un-infected Women
The Quality of Life and Viral Control Effect of AIDS Patients After Long-acting Injection of Cabotegravir and Rilpivirine
ALHIV Smartphone Game Study
Mesenchymal Stem Cells Treatment for AIDS Patients at Late Stage
Safety & Efficacy of Dual Therapy With Raltegravir/Lamivudine
The MISTRAL Study: Gut Microbiome Correlates of Serious AIDS and Non-AIDS Events
Randomized Trial of Liposomal Amphotericin B for Histoplasmosis in AIDS Patients
Economic Navigation and Strengthening to Research Unrestricted Services for Transgender Women (ENTRUST)
Standardized Patients to Measure and Address Intersectional Stigma